Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2021

01-12-2021 | Lung Cancer | Thoracic Oncology

Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma

Authors: Xu-Heng Chiang, MD, Tzu-Pin Lu, PhD, Min-Shu Hsieh, MD, PhD, Tung-Ming Tsai, MD, Hsien-Chi Liao, MD, Tzu-Ning Kao, MD, Chia-Hong Chang, MS, Mong-Wei Lin, MD, PhD, Hsao-Hsun Hsu, MD, PhD, Jin-Shing Chen, MD, PhD

Published in: Annals of Surgical Oncology | Issue 13/2021

Login to get access

Abstract

Background

The choice between wedge resection and segmentectomy as a sublobar resection method for patients with cT1N0 lung cancer remains debatable. This study aimed to evaluate the clinical outcomes after wedge resection and segmentectomy for patients with cT1N0 lung adenocarcinoma.

Methods

The study enrolled 1002 consecutive patients with cT1N0 lung adenocarcinoma who underwent sublobar resection at the authors’ institution between 2011 and 2017. A propensity score-matching analysis was used to compared the clinical outcomes between the wedge resection and segmentectomy groups.

Results

Wedge resection was performed for 810 patients (80.8%), and segmentectomy was performed for 192 patients (19.2%). Wedge resection resulted in better perioperative outcomes than segmentectomy. The multivariate analysis showed that the significant risk factors for poor disease-free survival (DFS) were elevated preoperative serum carcinoembryonic antigen levels, total tumor diameter greater than 2 cm, and a consolidation-to-tumor (C/T) ratio higher than 50%. After propensity-matching, no differences in overall survival or DFS were noted between the two matched groups. However, subgroup analysis showed that segmentectomy was associated with better DFS than wedge resection (p = 0.039) for the patients with a tumor diameter greater than 2 cm and a C/T ratio higher than 50%.

Conclusion

Segmentectomy is the appropriate surgical method for sublobar resection in cT1N0 lung adenocarcinoma patients with a tumor diameter greater than 2 cm and a C/T ratio higher than 50%. Wedge resection may be a safe and feasible sublobar resection method for patients with a tumor diameter of 2 cm or smaller or a C/T ratio of 50% or lower.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–522.CrossRef Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–522.CrossRef
2.
go back to reference de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503–13.CrossRef de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503–13.CrossRef
3.
go back to reference Aberle DR, Adams AM, Berg CD, et al. Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.CrossRef Aberle DR, Adams AM, Berg CD, et al. Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.CrossRef
4.
go back to reference Tsutani Y, Mimura T, Kai Y, et al. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017;154:1089–96.CrossRef Tsutani Y, Mimura T, Kai Y, et al. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017;154:1089–96.CrossRef
5.
go back to reference Razi SS, Nguyen D, Villamizar N. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease. J Thorac Cardiovasc Surg. 2020;159:2469–83.CrossRef Razi SS, Nguyen D, Villamizar N. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease. J Thorac Cardiovasc Surg. 2020;159:2469–83.CrossRef
6.
go back to reference Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.CrossRef Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.CrossRef
7.
go back to reference Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small cell lung cancer: post hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6:915–24.CrossRef Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small cell lung cancer: post hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6:915–24.CrossRef
8.
go back to reference Zhao M, Lu T, Huang Y, et al. Survival and long-term cause-specific mortality associated with stage IA lung adenocarcinoma after wedge resection vs segmentectomy: a population-based propensity score-matching and competing risk analysis. Front Oncol. 2019;9:593.CrossRef Zhao M, Lu T, Huang Y, et al. Survival and long-term cause-specific mortality associated with stage IA lung adenocarcinoma after wedge resection vs segmentectomy: a population-based propensity score-matching and competing risk analysis. Front Oncol. 2019;9:593.CrossRef
9.
go back to reference Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann Thorac Surg. 2018;105:1483–91.CrossRef Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann Thorac Surg. 2018;105:1483–91.CrossRef
10.
go back to reference Dai C, Shen J, Ren Y, et al. Choice of surgical procedure for patients with non-small cell lung cancer ≤1 cm or >1 to 2 cm among lobectomy, segmentectomy, and wedge resection: a population-based study. J Clin Oncol. 2016;34:3175–82.CrossRef Dai C, Shen J, Ren Y, et al. Choice of surgical procedure for patients with non-small cell lung cancer ≤1 cm or >1 to 2 cm among lobectomy, segmentectomy, and wedge resection: a population-based study. J Clin Oncol. 2016;34:3175–82.CrossRef
11.
go back to reference Razi SS, John MM, Sainathan S, Stavropoulos C. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a surveillance, epidemiology, and end results database analysis. J Surg Res. 2016;200:683–9.CrossRef Razi SS, John MM, Sainathan S, Stavropoulos C. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a surveillance, epidemiology, and end results database analysis. J Surg Res. 2016;200:683–9.CrossRef
12.
go back to reference Zhang Y, Sun Y, Chen H. A propensity score-matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma. Oncotarget. 2016;7:13880–5.CrossRef Zhang Y, Sun Y, Chen H. A propensity score-matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma. Oncotarget. 2016;7:13880–5.CrossRef
13.
go back to reference Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.CrossRef Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.CrossRef
14.
go back to reference Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth-edition lung cancer stage classification. Chest. 2017;151:193–203.CrossRef Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth-edition lung cancer stage classification. Chest. 2017;151:193–203.CrossRef
15.
go back to reference Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology. 1996;200:327–31.CrossRef Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology. 1996;200:327–31.CrossRef
16.
go back to reference Suzuki K, Koike T, Asakawa T, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011;6:751–6.CrossRef Suzuki K, Koike T, Asakawa T, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011;6:751–6.CrossRef
17.
go back to reference Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical, and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243–60.CrossRef Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical, and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243–60.CrossRef
18.
go back to reference Hung WT, Hung MH, Wang ML, Cheng YJ, Hsu HH, Chen JS. Nonintubated thoracoscopic surgery for lung tumor: seven years’ experience with 1025 patients. Ann Thorac Surg. 2019;107:1607–12.CrossRef Hung WT, Hung MH, Wang ML, Cheng YJ, Hsu HH, Chen JS. Nonintubated thoracoscopic surgery for lung tumor: seven years’ experience with 1025 patients. Ann Thorac Surg. 2019;107:1607–12.CrossRef
19.
go back to reference Lin MW, Tseng YH, Lee YF, et al. Computed tomography-guided patent blue vital dye localization of pulmonary nodules in uniportal thoracoscopy. J Thorac Cardiovasc Surg. 2016;152:535–44.CrossRef Lin MW, Tseng YH, Lee YF, et al. Computed tomography-guided patent blue vital dye localization of pulmonary nodules in uniportal thoracoscopy. J Thorac Cardiovasc Surg. 2016;152:535–44.CrossRef
20.
go back to reference Brunelli A, Cassivi SD, Salati M, et al. Digital measurements of air leak flow and intrapleural pressures in the immediate postoperative period predict risk of prolonged air leak after pulmonary lobectomy. Eur J Cardiothorac Surg. 2011;39:584–8.CrossRef Brunelli A, Cassivi SD, Salati M, et al. Digital measurements of air leak flow and intrapleural pressures in the immediate postoperative period predict risk of prolonged air leak after pulmonary lobectomy. Eur J Cardiothorac Surg. 2011;39:584–8.CrossRef
21.
go back to reference Austin PC. Optimal caliper widths for propensity score-matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150–61.CrossRef Austin PC. Optimal caliper widths for propensity score-matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150–61.CrossRef
22.
go back to reference Grose E, Wilson S, Barkun J, et al. Use of propensity score methodology in contemporary high-impact surgical literature. J Am Coll Surg. 2020;230:101–12.CrossRef Grose E, Wilson S, Barkun J, et al. Use of propensity score methodology in contemporary high-impact surgical literature. J Am Coll Surg. 2020;230:101–12.CrossRef
23.
go back to reference Chiang XH, Hsu HH, Hsieh MS, et al. Propensity-matched analysis comparing survival after sublobar resection and lobectomy for cT1N0 lung adenocarcinoma. Ann Surg Oncol. 2020;27:703–15.CrossRef Chiang XH, Hsu HH, Hsieh MS, et al. Propensity-matched analysis comparing survival after sublobar resection and lobectomy for cT1N0 lung adenocarcinoma. Ann Surg Oncol. 2020;27:703–15.CrossRef
24.
go back to reference Kates M, Swanson S, Wisnivesky JP. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer ≤1 cm in size: a review of SEER data. Chest. 2011;139:491–6.CrossRef Kates M, Swanson S, Wisnivesky JP. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer ≤1 cm in size: a review of SEER data. Chest. 2011;139:491–6.CrossRef
25.
go back to reference Yoshimura M. Radical segmentectomy and wedge resection for good-risk patients with peripheral ct1an0m0 lung cancer radical segmentectomy and wedge resection for good-risk patients with peripheral ct1an0m0 lung cancer. Nihon Geka Gakkai Zasshi. 2016;117:278–82.PubMed Yoshimura M. Radical segmentectomy and wedge resection for good-risk patients with peripheral ct1an0m0 lung cancer radical segmentectomy and wedge resection for good-risk patients with peripheral ct1an0m0 lung cancer. Nihon Geka Gakkai Zasshi. 2016;117:278–82.PubMed
26.
go back to reference Filosso PL, Guerrera F, Falco NR, et al. Anatomical resections are superior to wedge resections for overall survival in patients with stage 1 typical carcinoids. Eur J Cardiothorac Surg. 2019;55:273–9.CrossRef Filosso PL, Guerrera F, Falco NR, et al. Anatomical resections are superior to wedge resections for overall survival in patients with stage 1 typical carcinoids. Eur J Cardiothorac Surg. 2019;55:273–9.CrossRef
27.
go back to reference Ha KJ, Yun JK, Lee GD, et al. Surgical outcomes of radiographically noninvasive lung adenocarcinoma according to surgical strategy: wedge resection, segmentectomy, and lobectomy. Korean J Thorac Cardiovasc Surg. 2018;51:376–83.CrossRef Ha KJ, Yun JK, Lee GD, et al. Surgical outcomes of radiographically noninvasive lung adenocarcinoma according to surgical strategy: wedge resection, segmentectomy, and lobectomy. Korean J Thorac Cardiovasc Surg. 2018;51:376–83.CrossRef
28.
go back to reference Zhong C, Sakurai H, Wei S, Fang W, Asamura H. Sublobar resections for small-sized stage Ia lung adenocarcinoma: a Sino-Japanese multicenter study. J Thorac Dis. 2018;10:991–8.CrossRef Zhong C, Sakurai H, Wei S, Fang W, Asamura H. Sublobar resections for small-sized stage Ia lung adenocarcinoma: a Sino-Japanese multicenter study. J Thorac Dis. 2018;10:991–8.CrossRef
29.
go back to reference Altorki NK, Kamel MK, Narula N, et al. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non-small cell lung cancer. J Thorac Oncol. 2016;11:1984–92.CrossRef Altorki NK, Kamel MK, Narula N, et al. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non-small cell lung cancer. J Thorac Oncol. 2016;11:1984–92.CrossRef
31.
go back to reference Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769–75.CrossRef Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg. 2006;132:769–75.CrossRef
32.
go back to reference Aokage K, Saji H, Suzuki K, et al. A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211). Gen Thorac Cardiovasc Surg. 2017;65:267–72.CrossRef Aokage K, Saji H, Suzuki K, et al. A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211). Gen Thorac Cardiovasc Surg. 2017;65:267–72.CrossRef
33.
go back to reference Kent M, Landreneau R, Mandrekar S, et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg. 2013;96:1747–54.CrossRef Kent M, Landreneau R, Mandrekar S, et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg. 2013;96:1747–54.CrossRef
34.
go back to reference Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141:662–70.CrossRef Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141:662–70.CrossRef
35.
go back to reference Moon Y, Lee KY, Park JK. Margin width of resected lepidic lung cancer does not affect recurrence after sublobar resection. World J Surg. 2018;42:1449–57.CrossRef Moon Y, Lee KY, Park JK. Margin width of resected lepidic lung cancer does not affect recurrence after sublobar resection. World J Surg. 2018;42:1449–57.CrossRef
Metadata
Title
Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma
Authors
Xu-Heng Chiang, MD
Tzu-Pin Lu, PhD
Min-Shu Hsieh, MD, PhD
Tung-Ming Tsai, MD
Hsien-Chi Liao, MD
Tzu-Ning Kao, MD
Chia-Hong Chang, MS
Mong-Wei Lin, MD, PhD
Hsao-Hsun Hsu, MD, PhD
Jin-Shing Chen, MD, PhD
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10213-9

Other articles of this Issue 13/2021

Annals of Surgical Oncology 13/2021 Go to the issue